We examine whether intracoronary (ic) abciximab bolus-only regimen which provides high local drug concentration, a most cost-efffective option, is as effective and safe as the standard iv bolus and infusion regime. Methods: A total of 195 consecutive patients who underwent PPCI for STEMI from 2001 to 2007 in whom abciximab was administered were enrolled.